Literature DB >> 24695619

Applications of Biophysics in High-Throughput Screening Hit Validation.

Christine Clougherty Genick1, Danielle Barlier2, Dominique Monna2, Reto Brunner2, Céline Bé3, Clemens Scheufler3, Johannes Ottl2.   

Abstract

For approximately a decade, biophysical methods have been used to validate positive hits selected from high-throughput screening (HTS) campaigns with the goal to verify binding interactions using label-free assays. By applying label-free readouts, screen artifacts created by compound interference and fluorescence are discovered, enabling further characterization of the hits for their target specificity and selectivity. The use of several biophysical methods to extract this type of high-content information is required to prevent the promotion of false positives to the next level of hit validation and to select the best candidates for further chemical optimization. The typical technologies applied in this arena include dynamic light scattering, turbidometry, resonance waveguide, surface plasmon resonance, differential scanning fluorimetry, mass spectrometry, and others. Each technology can provide different types of information to enable the characterization of the binding interaction. Thus, these technologies can be incorporated in a hit-validation strategy not only according to the profile of chemical matter that is desired by the medicinal chemists, but also in a manner that is in agreement with the target protein's amenability to the screening format. Here, we present the results of screening strategies using biophysics with the objective to evaluate the approaches, discuss the advantages and challenges, and summarize the benefits in reference to lead discovery. In summary, the biophysics screens presented here demonstrated various hit rates from a list of ~2000 preselected, IC50-validated hits from HTS (an IC50 is the inhibitor concentration at which 50% inhibition of activity is observed). There are several lessons learned from these biophysical screens, which will be discussed in this article.
© 2014 Society for Laboratory Automation and Screening.

Entities:  

Keywords:  differential scanning fluorimetry; dynamic light scattering; resonance waveguide; surface plasmon resonance; turbidometry

Mesh:

Substances:

Year:  2014        PMID: 24695619     DOI: 10.1177/1087057114529462

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  6 in total

Review 1.  Biophysics in drug discovery: impact, challenges and opportunities.

Authors:  Jean-Paul Renaud; Chun-Wa Chung; U Helena Danielson; Ursula Egner; Michael Hennig; Roderick E Hubbard; Herbert Nar
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

Review 2.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

3.  The grand challenge: use of a new approach in developing policies in the area of radiation and health.

Authors:  Dariusz Leszczynski
Journal:  Front Public Health       Date:  2014-05-21

4.  Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors.

Authors:  Kristoff T Homan; Kelly M Larimore; Jonathan M Elkins; Marta Szklarz; Stefan Knapp; John J G Tesmer
Journal:  ACS Chem Biol       Date:  2014-10-03       Impact factor: 5.100

Review 5.  Biophysical methods in early drug discovery.

Authors:  Geoffrey Holdgate; Kevin Embrey; Alexander Milbradt; Gareth Davies
Journal:  ADMET DMPK       Date:  2019-12-11

Review 6.  Epigenetic assays for chemical biology and drug discovery.

Authors:  Sheraz Gul
Journal:  Clin Epigenetics       Date:  2017-04-21       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.